Putting genome data into the public domain advances science, but nearly all of it can be linked to someone.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
By reviving lost species, a new company could put a warm and fuzzy face on advanced reproductive engineering.
Advances in genetic engineering have some biologists convinced they’ll re-create extinct species.
Getting you to take your eyes off the road could be worth billions in new search revenue to Google.
Smartphones, tablets, and wireless data plans are already a trillion-dollar business. It’s just the beginning.
A Russian mogul uses a science award to spread Internet millions among university biologists. Is he after a cure for cancer?
A leading neuroscientist says Kurzweil’s Singularity isn’t going to happen. Instead, humans will assimilate machines.
Did Obama’s State of the Union speech include more mentions of technology than any other president’s?
Rethink Robotics invented a $22,000 humanoid robot that competes with low-wage workers.
Bringing manufacturing jobs back to the U.S. is politically savvy and can make economic sense.